[Federal Register Volume 85, Number 231 (Tuesday, December 1, 2020)]
[Notices]
[Pages 77243-77249]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26443]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-508F]


Final Adjusted Aggregate Production Quotas for Schedule I and II 
Controlled Substances and Assessment of Annual Needs for the List I 
Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Final order.

-----------------------------------------------------------------------

SUMMARY: This final order establishes the final adjusted 2020 aggregate 
production quotas for controlled substances in schedules I and II of 
the Controlled Substances Act and the assessment of annual needs for 
the list I chemicals ephedrine, pseudoephedrine, and 
phenylpropanolamine.

DATES: This order is effective December 1, 2020.

FOR FURTHER INFORMATION CONTACT: Scott A. Brinks, Regulatory Drafting 
and Policy Support Section, Diversion Control Division, Drug 
Enforcement Administration; Mailing Address: 8701 Morrissette Drive, 
Springfield, VA 22152, Telephone: (571) 362-3261.

SUPPLEMENTARY INFORMATION:

Legal Authority

    Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) 
requires the Attorney General to establish aggregate production quotas 
(APQ) for each basic class of controlled substances listed in schedules 
I and II and for the list I chemicals ephedrine, pseudoephedrine, and 
phenylpropanolamine. The Attorney General has delegated this function 
to the Administrator of the Drug Enforcement Administration (DEA) 
pursuant to 28 CFR 0.100.

Background

    DEA published the 2020 established APQ for controlled substances in 
schedules I and II and for the assessment of annual needs (AAN) for the 
list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine in 
the Federal Register on December 2, 2019. 84 FR 66014. DEA is committed 
to preventing and limiting diversion by enforcing laws and regulations 
regarding controlled substances and the list I chemicals ephedrine, 
pseudoephedrine, and phenylpropanolamine, while meeting the legitimate 
medical, scientific, and export needs of the United States. This notice 
stated that the Administrator would adjust, as needed, the established 
APQ in 2020 in accordance with 21 CFR 1303.13 and 21 CFR 1315.13.
    In response to the public health emergency declared by the 
Secretary of Health and Human Services (HHS) on January 31, 2020, DEA 
published the final order titled ``Adjustments to Aggregate Production 
Quotas for Certain Schedule II Controlled Substances and Assessment of 
Annual Needs for the List I Chemicals Ephedrine and Pseudoephedrine for 
2020'' on April 10, 2020. (85 FR 20302). While the adjustments were 
effective immediately, all interested persons were invited to comment 
on or object to the adjustments on or before May 11, 2020.
    The 2020 proposed adjusted APQ for controlled substances in 
schedules I and II and AAN for the list I chemicals

[[Page 77244]]

ephedrine, pseudoephedrine, and phenylpropanolamine were subsequently 
published in the Federal Register on September 1, 2020, (85 FR 54414), 
after consideration of the criteria outlined in that notice. All 
interested persons were invited to comment on or object to the proposed 
APQs and AANs on or before October 1, 2020.

Comments Received

    DEA received five timely comments and one untimely comment in 
response to the April Federal Register notice and nine comments in 
response to the September Federal Register notice from patients, DEA-
registered entities, and non-DEA entities. The comments included 
appreciation of DEA's response to the public health emergency, concerns 
about potential drug shortages, interference with doctor-patient 
relationships, and comments outside the scope of this final order.
    Issue: Commenters expressed appreciation of DEA's flexibility in 
responding to the nationwide public health emergency declared by the 
Secretary of HHS on January 31, 2020, by adjusting APQ for select 
schedule II controlled substances and list I chemicals.
    DEA Response: DEA acknowledges the expressions of appreciation to 
changes in the APQ and AAN. The adjustments to select schedule II 
controlled substances and list I chemicals occurred after DEA consulted 
with HHS and determined the utilization rates for these drugs 
substantially increased due to the treatment regimens for ventilator 
patients stricken with the Coronavirus Disease of 2019 (COVID-19) 
compared to the previously estimated annual consumption rates. While 
the estimates from HHS provided a wide range in the number of patients 
that would require ventilation treatment due to COVID-19, DEA could, 
under 21 CFR 1303.13 and 1315.13, adjust the APQ and AAN for schedule 
II controlled substances and list I chemicals, respectively, to ensure 
manufacturing activities cover the upper range of the estimate could 
occur in a timely manner. DEA highlights factor 21 CFR 1303.13(b)(5) 
specifically, which allowed the Acting Administrator to increase the 
APQ and AAN for select controlled substances and list I chemicals to 
meet additional estimated medical needs as determined by HHS due to the 
unforeseen emergency caused by the COVID-19 pandemic.
    Issue: Commenters expressed general concerns that decreasing the 
APQ of controlled substances could lead to shortages of controlled 
substance medications.
    One DEA-registered entity submitted a comment requesting the APQ 
for hydrocodone (for sale) and oxycodone (for sale) be sufficient to 
provide for the estimated medical, scientific, research, and industrial 
needs of the United States, for export requirements, and for the 
establishment and maintenance of reserve stocks.
    DEA Response: DEA sets APQ in a manner to ensure that the estimated 
medical, scientific, research, industrial needs of the United States, 
lawful export requirements, and for the establishment and maintenance 
of reserve stocks. As discussed in both notices for adjustments, any 
adjustments to the APQ for controlled substances is based on factors 
set forth in 21 CFR 1303.13. In the event of a shortage, the CSA 
provides a mechanism under which DEA will, in appropriate 
circumstances, increase quotas to address shortages. 21 U.S.C. 826(h). 
Under 21 U.S.C. 826(h)(1), after receiving a request to address a 
shortage, DEA has 30 days to complete review of the request and 
determine whether adjustments are necessary to address the shortage. If 
adjustments are necessary, DEA is required to increase the APQ and 
individual production quotas to alleviate the shortage. Id. If DEA 
determines adjustments are not necessary, DEA is required to ``provide 
a written response detailing the basis for the . . . determination.'' 
Id. In addition to what Section 826(h)(1) requires, when DEA is 
notified of an alleged shortage, DEA will confer with the U.S. Food and 
Drug Administration and relevant manufacturers regarding the amount of 
material in physical inventory, current quota granted, and the 
estimated legitimate medical need, to determine whether a quota 
adjustment is necessary to alleviate any factually valid shortage.
    In accordance with 21 CFR 1303.13, DEA considered the comments for 
hydrocodone (for sale) and oxycodone (for sale), and the Acting 
Administrator determined the proposed adjusted 2020 APQs for these 
substances as published in the Federal Register on September 1, 2020, 
(85 FR 54414), are sufficient to meet the current 2020 estimated 
medical, scientific, research, and industrial needs of the United 
States, and to provide for adequate reserve stock.
    Issue: DEA received comments of general concerns alleging decreases 
to the APQ interfered with doctor-patient relationships.
    DEA Response: In determining the APQ, DEA considers prescriptions 
that have been issued. However, DEA does not interfere with doctor-
patient relationships. Doctors authorized to dispense controlled 
substances are responsible for adhering to the laws and regulations set 
forth under the CSA, which requires doctors to only write prescriptions 
for a legitimate medical need. DEA is responsible for enforcing 
controlled substance laws and regulations, and is committed to ensuring 
an adequate and uninterrupted supply of controlled substances in order 
to meet the demand of legitimate medical, scientific, and export needs 
of the United States.
    Untimely Comment Issue: The DEA received one comment from a DEA-
registered entity for previously established value of the 2020 AAN for 
pseudoephedrine (for conversion), requesting an increase because the 
established AAN is not adequate to cover the commenter's new projected 
need for 2020.
    DEA Response: The comment was received in between the comment 
periods for the two notices of adjustment. Even though the comment was 
outside the comment period that ended on May 11, 2020, DEA considered 
this comment as part of the second comment period ending on October 1, 
2020, when setting the final 2020 AAN.
    Out of Scope Comments: DEA received comments on issues outside the 
scope of this final order. The comments were general in nature and 
raised issues of specific medical illnesses, medical treatments, and 
medication costs, and therefore, are outside of the scope of this Final 
Order for 2020 and do not impact the original analysis involved in 
finalizing the 2020 APQ.

Analysis for Final Adjusted 2020 Aggregate Production Quotas and 
Assessment of Annual Needs

    In determining the final adjusted 2020 APQ and AAN, DEA has 
considered the above comments relevant to this Final Order for calendar 
year 2020, along with the factors set forth in 21 CFR 1303.13 and 21 
CFR 1315.13, in accordance with 21 U.S.C. 826(a). DEA has also 
considered other relevant factors, including the 2019 year-end 
inventories, initial 2020 manufacturing and import quotas, 2020 export 
requirements, actual and projected 2020 sales, research and product 
development requirements, additional applications received, and the 
extent of any diversion of the controlled substance in the class. Based 
on all of the above, the Acting Administrator is adjusting the 2020 APQ 
for the following: Increases for

[[Page 77245]]

Amphetamine (for sale) and Methamphetamine, based on the data received 
since the publication of the 2020 proposed adjustment for APQ and AAN 
in the Federal Register on September 1, 2020 (85 FR 54414); increases 
for Crotonyl Fentanyl, Ethylone, and Isotonitazene due to the 
publication of their schedule I temporary controlled status; and 
increases for Etonitazene due to additional manufacturers entering the 
reference standard market. This final order reflects those adjustments.
    Pursuant to the above, the Acting Administrator hereby finalizes 
the 2020 APQ for the following schedule I and II controlled substances 
and the 2020 AAN for the list I chemicals ephedrine, pseudoephedrine, 
and phenylpropanolamine, expressed in grams of anhydrous acid or base, 
as follows:

------------------------------------------------------------------------
                                                           Final revised
                                                            2020 quotas
                       Basic class                       ---------------
                                                                (g)
------------------------------------------------------------------------
                    Temporarily Scheduled Substances
------------------------------------------------------------------------
Crotonyl fentanyl.......................................              25
Ethylone................................................              25
Isotonitazene...........................................              25
------------------------------------------------------------------------
                               Schedule I
------------------------------------------------------------------------
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine..................              20
1-(1-Phenylcyclohexyl)pyrrolidine.......................              15
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine..........              10
1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201).......              30
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694)......              30
1-Benzylpiperazine......................................              25
1-Methyl-4-phenyl-4-propionoxypiperidine................              10
1-[1-(2-Thienyl)cyclohexyl]piperidine...................              15
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)........              30
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).......              30
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).......              30
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)...              30
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)................             100
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-                                 30
 methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B;
 Cimbi-36)..............................................
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).......              30
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-                                25
 methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C;
 Cimbi-82)..............................................
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).........              30
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-                                  30
 methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I;
 Cimbi-5)...............................................
2,5-Dimethoxy-4-ethylamphetamine (DOET).................              25
2,5-Dimethoxy-4-(n)-propylthiophenethylamine............              25
2,5-Dimethoxyamphetamine (DMA)..........................              25
2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine (2C-T-2)..              30
2-(4-(Isopropylthio)-2,5-dimethoxyphenyl)ethanamine (2C-              30
 T-4)...................................................
3,4,5-Trimethoxyamphetamine.............................              30
3,4-Methylenedioxyamphetamine (MDA).....................              55
3,4-Methylenedioxymethamphetamine (MDMA)................              50
3,4-Methylenedioxy-N-ethylamphetamine (MDEA)............              40
3,4-Methylenedioxy-N-methylcathinone (methylone)........              40
3,4-Methylenedioxypyrovalerone (MDPV)...................              35
3-Fluoro-N-methylcathinone (3-FMC)......................              25
3-Methylfentanyl........................................              30
3-Methylthiofentanyl....................................              30
4-Bromo-2,5-dimethoxyamphetamine (DOB)..................              30
4-Bromo-2,5-dimethoxyphenethylamine (2-CB)..............              25
4-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-alpha-              25
 PVP)...................................................
1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1 H-indazole-3-              25
 carboximide (4CN-Cumyl-Butinaca).......................
4-Fluoroisobutyryl fentanyl.............................              30
4-Fluoro-N-methylcathinone (4-FMC; Flephedrone).........              25
4-Methyl-N-ethylcathinone (4-MEC).......................              25
4-Methoxyamphetamine....................................             150
4-Methyl-2,5-dimethoxyamphetamine (DOM).................              25
4-Methylaminorex........................................              25
4-Methyl-N-methylcathinone (mephedrone).................              45
4-Methyl-alpha-ethylaminopentiophenone (4-MEAP).........              25
4-Methyl-alpha-pyrrolidinohexiophenone (MPHP)...........              25
4-Methyl-alpha-pyrrolidinopropiophenone (4-MePPP).......              25
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-                50
 phenol.................................................
5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-                  40
 phenol (cannabicyclohexanol or CP-47,497 C8-homolog)...
5F-CUMYL-PINACA.........................................              25
5F-EDMB-PINACA..........................................              25
5F-MDMB-PICA............................................              25
5F-AB-PINACA; N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-              25
 fluoropentyl)-1H-indazole-3-carboxamide................
5F-CUMYL-P7AICA; (1-(5-fluoropentyl)-N-(2-phenylpropan-2-             25
 yl)-1H-pyrrolo[2,3-b]pyridine-3-carboximide)...........
5F-ADB; 5F-MDMB-PINACA (methyl 2-(1-(5-fluoropentyl)-1H-              30
 indazole-3-carboxamido)-3,3-dimethylbutanoate).........

[[Page 77246]]

 
5F-AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-                   30
 carboxamido)-3-methylbutanoate)........................
5F-APINACA; 5F-AKB48 (N-(adamantan-1-yl)-1-(5-                        30
 fluoropentyl)-1H-indazole-3-carboxamide)...............
5-Fluoro-PB-22; 5F-PB-22................................              20
5-Fluoro-UR144, XLR11 ([1-(5-fluoro-pentyl)-1H-indol-3-               25
 yl](2,2,3,3-tetramethylcyclopropyl)methanone...........
5-Methoxy-3,4-methylenedioxyamphetamine.................              25
5-Methoxy-N,N-diisopropyltryptamine.....................              25
5-Methoxy-N,N-dimethyltryptamine........................              25
AB-CHMINACA.............................................              30
AB-FUBINACA.............................................              50
AB-PINACA...............................................              30
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-             30
 (4-fluorobenzyl)-1H-indazole-3-carboxamide)............
Acetorphine.............................................              25
Acetyl Fentanyl.........................................             100
Acetyl-alpha-methylfentanyl.............................              30
Acetyldihydrocodeine....................................              30
Acetylmethadol..........................................              25
Acryl Fentanyl..........................................              25
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-               50
 pentyl-1H-indazole-3-carboxamide)......................
AH-7921.................................................              30
Allylprodine............................................              25
Alphacetylmethadol......................................              25
Alpha-Ethyltryptamine...................................              25
Alphameprodine..........................................              25
Alphamethadol...........................................              25
Alphaprodine............................................              25
Alpha-Methylfentanyl....................................              30
Alpha-Methylthiofentanyl................................              30
Alpha-Methyltryptamine (AMT)............................              25
Alpha-Pyrrolidinobutiophenone ([alpha]-PBP).............              25
Alpha-Pyrrolidinoheptaphenone (PV8).....................              25
Alpha-Pyrrolidinohexanophenone ([alpha]-PHP)............              25
Alpha-Pyrrolidinopentiophenone ([alpha]-PVP)............              25
Aminorex................................................              25
Anileridine.............................................              20
APINACA, AKB48 (N-(1-adamantyl)-1-pentyl-1H-indazole-3-               25
 carboxamide)...........................................
Benzethidine............................................              25
Benzylmorphine..........................................              30
Betacetylmethadol.......................................              25
Beta-Hydroxy-3-methylfentanyl...........................              30
Beta-Hydroxyfentanyl....................................              30
Beta-Hydroxythiofentanyl................................              30
Betameprodine...........................................              25
Betamethadol............................................               4
Betaprodine.............................................              25
Bufotenine..............................................              15
Butylone................................................              25
Butyryl fentanyl........................................              30
Cathinone...............................................              40
Clonitazene.............................................              25
Codeine methylbromide...................................              30
Codeine-N-oxide.........................................             192
Cyclopentyl Fentanyl....................................              30
Cyclopropyl Fentanyl....................................              20
Cyprenorphine...........................................              25
Desomorphine............................................              25
Dextromoramide..........................................              25
Diampromide.............................................              20
Diethylthiambutene......................................              20
Diethyltryptamine.......................................              25
Difenoxin...............................................           9,200
Dihydromorphine.........................................         753,500
Dimenoxadol.............................................              25
Dimepheptanol...........................................              25
Dimethylthiambutene.....................................              20
Dimethyltryptamine......................................              50
Dioxaphetyl butyrate....................................              25
Dipipanone..............................................              25
Drotebanol..............................................              25
Ethylmethylthiambutene..................................              25
Etonitazene.............................................              25
Etorphine...............................................              30

[[Page 77247]]

 
Etoxeridine.............................................              25
Fenethylline............................................              30
Fentanyl related substances.............................             600
FUB-144.................................................              25
FUB-AKB48...............................................              25
FUB-AMB, MMB-Fubinaca, AMB-Fubinaca.....................              25
Furanyl fentanyl........................................              30
Furethidine.............................................              25
Gamma Hydroxybutyric Acid...............................      29,417,000
Heroin..................................................              45
Hydromorphinol..........................................              40
Hydroxypethidine........................................              25
Ibogaine................................................              30
Isobutyryl Fentanyl.....................................              25
JWH-018 and AM678 (1-Pentyl-3-(1-naphthoyl)indole)......              35
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).................              45
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).................              45
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole)......              30
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).......              30
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-                             35
 naphthoyl)indole)......................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).......              30
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole)......              30
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).......              30
Ketobemidone............................................              30
Levomoramide............................................              25
Levophenacylmorphan.....................................              25
Lysergic acid diethylamide (LSD)........................              40
MAB-CHMINACA; ADB-CHMINACA (N-(1-amino-3,3-dimethyl-1-                30
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
 carboxamide)...........................................
MDMB-CHMICA; MMB-CHMINACA (methyl 2-(1-                               30
 (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-
 dimethylbutanoate).....................................
MDMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole-              30
 3-carboxamido)-3,3-dimethylbutanoate)..................
MMB-CHMICA (AMB-CHMICA); Methyl-2-(1-(cyclohexylmethyl)-              25
 1H-indole-3-carboxamido)-3-methylbutanoate.............
Marihuana...............................................       3,200,000
Mecloqualone............................................              30
Mescaline...............................................              25
Methaqualone............................................              60
Methcathinone...........................................              25
Methoxyacetyl fentanyl..................................              30
Methyldesorphine........................................               5
Methyldihydromorphine...................................              25
Morpheridine............................................              25
Morphine methylbromide..................................               5
Morphine methylsulfonate................................               5
Morphine-N-oxide........................................             150
MT-45...................................................              30
Myrophine...............................................              25
NM2201; Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-               25
 carboxylate............................................
N,N-Dimethylamphetamine.................................              25
Naphyrone...............................................              25
N-Ethyl-1-phenylcyclohexylamine.........................              25
N-Ethyl-3-piperidyl benzilate...........................              10
N-Ethylamphetamine......................................              24
N-Ethylhexedrone........................................              25
N-Ethylpentylone, ephylone..............................              30
N-Hydroxy-3,4-methylenedioxyamphetamine.................              24
N-Methyl-3-Piperidyl Benzilate..........................              30
Nicocodeine.............................................              25
Nicomorphine............................................              25
Noracymethadol..........................................              25
Norlevorphanol..........................................              55
Normethadone............................................              25
Normorphine.............................................              40
Norpipanone.............................................              25
Ocfentanil..............................................              25
Ortho-fluorofentanyl, 2-fluorofentanyl..................              30
Para-chloroisobutyryl fentanyl..........................              30
Para-fluorofentanyl.....................................              25
Para-fluorobutyryl fentanyl.............................              25
Para-methoxybutyryl fentanyl............................              30
Parahexyl...............................................               5
PB-22; QUPIC............................................              20

[[Page 77248]]

 
Pentedrone..............................................              25
Pentylone...............................................              25
Phenadoxone.............................................              25
Phenampromide...........................................              25
Phenomorphan............................................              25
Phenoperidine...........................................              25
Pholcodine..............................................               5
Piritramide.............................................              25
Proheptazine............................................              25
Properidine.............................................              25
Propiram................................................              25
Psilocybin..............................................              30
Psilocyn................................................              50
Racemoramide............................................              25
SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2-                              45
 methoxyphenylacetyl)indole)............................
SR-19 and RCS-4 (1-Pentyl-3-[(4-methoxy)-benzoyl]indole)              30
Tetrahydrocannabinols...................................         384,460
Tetrahydrofuranyl fentanyl..............................              15
Thebacon................................................              25
Thiafentanil............................................              25
Thiofentanyl............................................              25
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-                           30
 yl](naphthalen-1-yl)methanone).........................
Tilidine................................................              25
Trimeperidine...........................................              25
UR-144 (1-pentyl-1H-indol-3-yl)(2,2,3,3-                              25
 tetramethylcyclopropyl)methanone.......................
U-47700.................................................              30
Valeryl fentanyl........................................              25
------------------------------------------------------------------------
                               Schedule II
------------------------------------------------------------------------
1-Phenylcyclohexylamine.................................              15
1-Piperidinocyclohexanecarbonitrile.....................              25
4-Anilino-N-phenethyl-4-piperidine (ANPP)...............         934,956
Alfentanil..............................................           3,260
Alphaprodine............................................              25
Amobarbital.............................................          20,100
Amphetamine (for conversion)............................      14,137,578
Amphetamine (for sale)..................................      44,330,000
Bezitramide.............................................              25
Carfentanil.............................................              20
Cocaine.................................................          73,090
Codeine (for conversion)................................       3,225,000
Codeine (for sale)......................................      35,341,292
Dextropropoxyphene......................................              35
Dihydrocodeine..........................................         156,713
Dihydroetorphine........................................              25
Diphenoxylate (for conversion)..........................          14,100
Diphenoxylate (for sale)................................         770,800
Ecgonine................................................          78,439
Ethylmorphine...........................................              30
Etorphine hydrochloride.................................              32
Fentanyl................................................         934,956
Glutethimide............................................              25
Hydrocodone (for conversion)............................           1,250
Hydrocodone (for sale)..................................      33,997,285
Hydromorphone...........................................       3,512,651
Isomethadone............................................              30
Levo-alphacetylmethadol (LAAM)..........................              25
Levomethorphan..........................................              30
Levorphanol.............................................          31,730
Lisdexamfetamine........................................      21,000,000
Meperidine..............................................       1,119,862
Meperidine Intermediate-A...............................              30
Meperidine Intermediate-B...............................              30
Meperidine Intermediate-C...............................              30
Metazocine..............................................              15
Methadone (for sale)....................................      25,619,700
Methadone Intermediate..................................      27,673,600
Methamphetamine.........................................       1,224,109
------------------------------------------------------------------------

[[Page 77249]]

 
[678,878 grams of levo-desoxyephedrine for use in a non-controlled, non-
 prescription product; 505,231 grams for methamphetamine mostly for
 conversion to a schedule III product; and 40,000 grams for
 methamphetamine (for sale).]
------------------------------------------------------------------------
Methylphenidate.........................................      57,438,334
Metopon.................................................              25
Moramide-intermediate...................................              25
Morphine (for conversion)...............................       3,376,696
Morphine (for sale).....................................      33,756,703
Nabilone................................................          62,000
Norfentanyl.............................................              25
Noroxymorphone (for conversion).........................      22,044,741
Noroxymorphone (for sale)...............................         376,000
Opium (powder)..........................................         250,000
Opium (tincture)........................................         530,837
Oripavine...............................................      33,010,750
Oxycodone (for conversion)..............................         725,998
Oxycodone (for sale)....................................      65,667,554
Oxymorphone (for conversion)............................      28,204,371
Oxymorphone (for sale)..................................         658,515
Pentobarbital...........................................      25,850,000
Phenazocine.............................................              25
Phencyclidine...........................................              35
Phenmetrazine...........................................              25
Phenylacetone...........................................              40
Piminodine..............................................              25
Racemethorphan..........................................               5
Racemorphan.............................................               5
Remifentanil............................................           3,000
Secobarbital............................................         172,100
Sufentanil..............................................           4,000
Tapentadol..............................................      13,447,541
Thebaine................................................      59,284,070
------------------------------------------------------------------------
                            List I Chemicals
------------------------------------------------------------------------
Ephedrine (for conversion)..............................             100
Ephedrine (for sale)....................................       4,756,000
Phenylpropanolamine (for conversion)....................      14,100,000
Phenylpropanolamine (for sale)..........................      16,590,000
Pseudoephedrine (for conversion)........................           1,000
Pseudoephedrine (for sale)..............................     200,382,900
------------------------------------------------------------------------

    The Acting Administrator further proposes that APQ for all other 
schedule I and II controlled substances included in 21 CFR 1308.11 and 
1308.12 remain at zero.

Timothy J. Shea,
Acting Administrator.
[FR Doc. 2020-26443 Filed 11-30-20; 8:45 am]
BILLING CODE 4410-09-P